Amine-reactive crosslinking enhances type 0 collagen hydrogel properties for regenerative medicine
Frontiers in Bioengineering and Biotechnology · 26.07.2024 · 12
DOI: 10.3389/fbioe.2024.1391728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 26.07.2024. Verfasst von Daniel Salthouse und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, Newcastle University, Newcastle Upon Tyne, United Kingdom. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
Introduction
Collagen is extensively utilised in regenerative medicine due to its highly desirable properties. However, collagen is typically derived from mammalian sources, which poses several limitations, including high cost, potential risk of immunogenicity and transmission of infectious diseases, and ethical and religious constraints. Jellyfish-sourced type 0 collagen represents a safer and more environmentally sustainable alternative collagen source.
Methods
Thus, we investigated the potential of jellyfish collagen-based hydrogels, obtained from Rhizostoma pulmo (R. pulmo) jellyfish, to be utilised in regenerative medicine. A variety of R. pulmo collagen hydrogels (RpCol hydrogels) were formed by adding a range of chemical crosslinking agents and their physicochemical and biological properties were characterised to assess their suitability for regenerative medicine applications. Results and Discussion The characteristic chemical composition of RpCol was confirmed by Fourier-transform infrared spectroscopy (FTIR), and the degradation kinetics, morphological, and rheological properties of RpCol hydrogels were shown to be adaptable through the addition of specific chemical crosslinking agents. The endotoxin levels of RpCol were below the Food and Drug Administration (FDA) limit for medical devices, thus allowing the potential use of RpCol in vivo . 8-arm polyethylene glycol succinimidyl carboxyl methyl ester (PEG-SCM)-crosslinked RpCol hydrogels preserved the viability and induced a significant increase in the metabolic activity of immortalised human mesenchymal stem/stromal cells (TERT-hMSCs), therefore demonstrating their potential to be utilised in a wide range of regenerative medicine applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Engineering, Newcastle University, Newcastle Upon Tyne, United Kingdom.
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
- Jellagen Limited, Cardiff, United Kingdom.
Förderung
- Engineering and Physical Sciences Research Council
Zitieren
APA
Salthouse, D., Goulding, P. D., Reay, S. L., Jackson, E. L., Xu, C., Ahmed, R., Mearns-Spragg, A., Novakovic, K., Hilkens, C. M. U., & Ferreira, A. M. (2024). Amine-reactive crosslinking enhances type 0 collagen hydrogel properties for regenerative medicine. Frontiers in Bioengineering and Biotechnology, 12. https://doi.org/10.3389/fbioe.2024.1391728
Vancouver
Salthouse D, Goulding PD, Reay SL, Jackson EL, Xu C, Ahmed R, et al. Amine-reactive crosslinking enhances type 0 collagen hydrogel properties for regenerative medicine. Frontiers in Bioengineering and Biotechnology. 2024;12. doi:10.3389/fbioe.2024.1391728
BibTeX
@article{Salthouse2024,
author = {Salthouse, Daniel and Goulding, Peter D and Reay, Sophie L and Jackson, Emma L and Xu, Chenlong and Ahmed, Rochelle and Mearns-Spragg, Andrew and Novakovic, Katarina and Hilkens, Catharien M U and Ferreira, Ana Marina},
title = {Amine-reactive crosslinking enhances type 0 collagen hydrogel properties for regenerative medicine},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2024},
volume = {12},
doi = {10.3389/fbioe.2024.1391728}
}
EUVIMED